ArticleJournal of translational medicine2019
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
Aruz Mesci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleJournal of translational medicine2019
Aruz Mesci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.